SEC Comment Letter for Predictive Oncology Inc. (AGPU) (CIK 0001446159) (AGPU) — Oct 6, 2014
Predictive Oncology Inc. (AGPU) (CIK 0001446159)
Date: Oct. 6, 2014 · CIK: 0001446159 · Accession: 0000000000-14-050056
AI Filing Summary & Sentiment
Reasoning
Letter
October 6 , 2014 Via E -Mail Joshua Kornberg Chief Executive Officer Skyline Medical Inc. 2915 Commers Drive, Suite 900 Eagan, Minnesota 55121
Re: Skyline Medical Inc. Registration Statement on Form S -1 Filed September 26, 2014 File No. 333 -198962
Dear Mr. Kornberg :
This is to advise you that we have not reviewed and will not review your registration statement .
We urge all persons who are responsible for the accuracy and adequacy of the disclosure in the filing to be certain that the filing includes the information the Securities Act of 193 3 and all applicable Securities Act rules require. Since the company and its management are in possession of all facts relating to a company’s disclosure, they are responsible for the accuracy and adequacy of the disclosures they have made.
In the event you request acceleration of the effective date of the pending regist ration statement please provide a written statement from the company acknowledging that:
should the Commission or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing;
the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and
the company may not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
Please refer to Rules 460 and 46 1 regarding requests for acceleration . We will consider a written request for acceleration of the effective date of the registration statement as confirmation
Joshua Kornberg Skyline Medical Inc. October 6 , 2014 Page 2
of the fact that those requesting acceleration are aware of their respective responsibilities un der the Securities Act of 1933 and the Securities Exchange Act of 1934 as they relate to the proposed public offering of the registered securities .
You may contact Jay Mumford at 202 -551-3637 with any questions.
Sincerely,
/s/ Jay Mumford for
Show Raw Text
October 6 , 2014
Via E -Mail
Joshua Kornberg
Chief Executive Officer
Skyline Medical Inc.
2915 Commers Drive, Suite 900
Eagan, Minnesota 55121
Re: Skyline Medical Inc.
Registration Statement on Form S -1
Filed September 26, 2014
File No. 333 -198962
Dear Mr. Kornberg :
This is to advise you that we have not reviewed and will not review your registration
statement .
We urge all persons who are responsible for the accuracy and adequacy of the disclosure
in the filing to be certain that the filing includes the information the Securities Act of 193 3 and
all applicable Securities Act rules require. Since the company and its management are in
possession of all facts relating to a company’s disclosure, they are responsible for the accuracy
and adequacy of the disclosures they have made.
In the event you request acceleration of the effective date of the pending regist ration
statement please provide a written statement from the company acknowledging that:
should the Commission or the staff, acting pursuant to delegated authority, declare the
filing effective, it does not foreclose the Commission from taking any action with respect
to the filing;
the action of the Commission or the staff, acting pursuant to delegated authority, in
declaring the filing effective, does not relieve the company from its full responsibility for
the adequacy and accuracy of the disclosure in the filing; and
the company may not assert staff comments and the declaration of effectiveness as a
defense in any proceeding initiated by the Commission or any person under the federal
securities laws of the United States.
Please refer to Rules 460 and 46 1 regarding requests for acceleration . We will consider a
written request for acceleration of the effective date of the registration statement as confirmation
Joshua Kornberg
Skyline Medical Inc.
October 6 , 2014
Page 2
of the fact that those requesting acceleration are aware of their respective responsibilities un der
the Securities Act of 1933 and the Securities Exchange Act of 1934 as they relate to the proposed
public offering of the registered securities .
You may contact Jay Mumford at 202 -551-3637 with any questions.
Sincerely,
/s/ Jay Mumford for
Amanda Ravitz
Assistant Director
cc: (via e -mail) Martin Rosenbaum, Esq.
Maslon Edelman Borman & Brand, LLP